Datagov Opendata Platform

The risk of recurrent stroke in stroke patients will increase, so the treatment to prevent recurrent stroke should be started early and continued for a long time. At present, it is recommended to use appropriate antiplatelet drugs to prevent the recurrence of ischemic stroke and other vascular diseases. According to research, patients with ischemic stroke or transient ischemic attack who receive antiplatelet drug treatment have a relative reduction in the rate of severe vascular diseases (including non-fatal myocardial infarction, non-fatal stroke, or vascular death) by 25%, and there are also studies showing that the relative risk of recurrent stroke can be reduced by 13% and 15% with antiplatelet drug treatment.